Tag Archives: Boehringer Ingelheim

Diabetes Drug Launch 2012: Tip-tops and Promo-flops

By Clark Herman | Published: October 12, 2012
With Halloween candy flooding the shelves in pharmacies across the nation, it’s only appropriate that we turn the conversation toward an ever-growing drug market and therapeutic area: diabetes.
Posted in Advertising, E-Media, FDA, Marketing, Meetings, Strategy | Also tagged , , , , | 1 Comment

Feds End Use of Seven Inhalers (But Not All At Once)

By George Koroneos | Published: April 14, 2010
Image by noii’s via Flickr FDA, on Tuesday, announced that it would phase out the use of seven asthma and chronic obstructive pulmonary disease inhalers to keep in check with regulations banning devices containing chlorofluorocarbons (CFCs). Four of the devices have already been discontinued, and the manufacturers of the remaining devices will have to find suitable replacements [...]
Posted in Regulatory, Strategy | Also tagged , , , , , , | Leave a comment